{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:39:40Z","timestamp":1785220780775,"version":"3.55.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>PCOS remains one of the most intriguing endocrine disorders that physicians encounter even though it was first described over 80 years ago. Although the diagnostic criteria, nomenclature, and ideal therapeutic strategies are areas of active and ongoing debate, there is no doubt that we have made tremendous progress in improving the quality of life and reproductive outcomes of women who suffer from this wide-ranging disorder.<\/jats:p>","DOI":"10.1097\/grf.0000000000000449","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T11:40:31Z","timestamp":1555587631000},"page":"271-281","source":"Crossref","is-referenced-by-count":6,"title":["Contemporary Management of Polycystic Ovarian Syndrome"],"prefix":"10.1097","volume":"62","author":[{"given":"LILLI D.","family":"ZIMMERMAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT","family":"SETTON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIGEL","family":"PEREIRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZEV","family":"ROSENWAKS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0015-0282(16)57589-X","article-title":"A disorder without identity: \u201cHCA,\u201d \u201cPCO,\u201d \u201cPCOD,\u201d \u201cPCOS,\u201d \u201cSLS\u201d. What are we to call it?!","volume":"63","author":"Lobo","year":"1995","journal-title":"Fertil Steril"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1210\/jc.2013-2978","article-title":"Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome","volume":"99","author":"Teede","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.fertnstert.2017.09.030","article-title":"Polycystic ovary syndrome, an enigmatic syndrome begging for a name change","volume":"108","author":"Rosenwaks","year":"2017","journal-title":"Fertil Steril"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jc.2004-2301","article-title":"Distribution of facial and body hair in unselected black and white women: towards a populational definition of hirsutism","volume":"91","author":"DeUgarte","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.fertnstert.2011.06.040","article-title":"Defining hirsutism in Chinese women: a cross sectional study","volume":"96","author":"Zhao","year":"2011","journal-title":"Fertil Setril"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jcem-57-2-393","article-title":"Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome","volume":"57","author":"Lobo","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","article-title":"Women with polycystic ovary syndrome gain regular menstrual cycles when ageing","volume":"15","author":"Elting","year":"2000","journal-title":"Hum Reprod"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"E1967","DOI":"10.1210\/jc.2013-2815","article-title":"The severity of menstrual dysfunction as a predictor of insulin resistance in patients polycystic ovary syndrome","volume":"98","author":"Brower","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.fertnstert.2008.06.021","article-title":"The degree of hyperinsulinemia, independent of androgen levels, is an important determination of the severity of hirsutism in PCOS","volume":"92","author":"Landay","year":"2009","journal-title":"Fertil Steril"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","article-title":"Polycystic ovary syndrome. Practice Bulletin No. 194","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R19-20230911","first-page":"e285","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement: executive summary","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/09513599909167586","article-title":"Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a population study","volume":"13","author":"Waggoner","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1210\/jcem-55-5-866","article-title":"Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"55","author":"Lee","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI108400","article-title":"Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome","volume":"57","author":"Rebar","year":"1976","journal-title":"J Clin Invest"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/humupd\/dmm030","article-title":"Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review","volume":"14","author":"Jones","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0037-1603096","article-title":"PCOS: long term health consequences","volume":"35","author":"Zore","year":"2017","journal-title":"Semin Reprod Med"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20230911","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum Reprod"},{"key":"R33-20230911","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0015-0282(16)56632-1","article-title":"Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women","volume":"61","author":"Guzick","year":"1994","journal-title":"Fertil Steril"},{"key":"R34-20230911","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-20230911","first-page":"1237","article-title":"Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial","volume":"32","author":"Smith","year":"2006","journal-title":"Dermatol Surg"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0002-9378(39)90764-7","article-title":"Surgical treatment of bilateral polycystic ovaries","volume":"38","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"R38-20230911","first-page":"956","article-title":"Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope","volume":"49","author":"Gj\u00f6nnaess","year":"1984","journal-title":"Fertil Steril"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Human Reprod Update"},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10397-005-0099-3","article-title":"Laparoscopic ovarian drilling (LOD) in patients with polycystic ovary syndrome (PCOS): an alternative approach to medical treatment?","volume":"2","author":"Strowitzki","year":"2005","journal-title":"Gynecol Surg"},{"key":"R41-20230911","first-page":"1","article-title":"Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome","volume":"6","author":"Farquhar","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Acher","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-20230911","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2017.06.026","article-title":"Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline","volume":"108","year":"2017","journal-title":"Fertil Steril"},{"key":"R45-20230911","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/humrep\/deh440","article-title":"Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome","volume":"19","author":"Kashyap","year":"2004","journal-title":"Human Reprod"},{"key":"R46-20230911","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, Metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"R47-20230911","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"R48-20230911","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cct.2011.12.005","article-title":"The pregnancy in polycystic ovary syndrome II (PPCOS II) trial: Rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome","volume":"33","author":"Legro","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"R49-20230911","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.fertnstert.2018.11.030","article-title":"A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome","volume":"111","author":"Mejia","year":"2019","journal-title":"Fertil Steril"},{"key":"R50-20230911","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0030-1265674","article-title":"Ovarian hyperstimulation syndrome prevention strategies: reducing the human chorionic gonadotropin trigger dose","volume":"28","author":"Kashyap","year":"2010","journal-title":"Semin Reprod Med"},{"key":"R51-20230911","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1210\/jc.2015-3676","article-title":"Reducing the risk of OHSS by GnRH Agonist triggering","volume":"100","author":"Casper","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-20230911","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus frozen embryos for infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201906000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:12:39Z","timestamp":1694419959000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201906000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000449","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}